Deltec Asset Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,667
| Closed | -$4.5K | – | 184 |
|
|
2022
Q4 | $4.5K | Hold |
1,667
| – | – | ﹤0.01% | 164 |
|
|
2022
Q3 | $7K | Hold |
1,667
| – | – | ﹤0.01% | 224 |
|
|
2022
Q2 | $12K | Hold |
1,667
| – | – | ﹤0.01% | 234 |
|
|
2022
Q1 | $20K | Hold |
1,667
| – | – | ﹤0.01% | 257 |
|
|
2021
Q4 | $31K | Hold |
1,667
| – | – | 0.01% | 254 |
|
|
2021
Q3 | $42K | Sell |
1,667
-19,805
| -92% | -$499K | 0.01% | 273 |
|
|
2021
Q2 | $1.36M | Sell |
21,472
-3,055
| -12% | -$193K | 0.19% | 85 |
|
|
2021
Q1 | $3.02M | Sell |
24,527
-4,576
| -16% | -$564K | 0.45% | 50 |
|
|
2020
Q4 | $3.31M | Buy |
+29,103
| New | +$3.31M | 0.51% | 50 |
|